BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7656857)

  • 1. [Interferon-alpha in chronic hepatitis C].
    Swobodnik W
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1186. PubMed ID: 7656857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hepatitis C with interferon-alpha in hemodialysis patients].
    Degos F
    Nephrologie; 1997; 18(7):279-80. PubMed ID: 9496567
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
    Mels GC; Roffi L; Antonelli G; Bellati G; Pacchetti S; Di Nolfo MA; Panizzuti F; Moretti G; Piperno A; Pozzi M
    Prog Clin Biol Res; 1993; 382():359-64. PubMed ID: 8502704
    [No Abstract]   [Full Text] [Related]  

  • 4. [Predictive factors of response to interferon-alpha treatment in chronic hepatitis C].
    Buti M; Esteban R
    Rev Esp Enferm Dig; 1997 Jul; 89(7):501-2. PubMed ID: 9303619
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C].
    Perreard M; Constant T; Monges D; Djaghri N; Angeli-Besson C; Gerolami A
    Gastroenterol Clin Biol; 1994; 18(11):1051. PubMed ID: 7705576
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alpha-interferon in the treatment of chronic hepatitis C in children].
    Cinquetti M; Marchi D
    Pediatr Med Chir; 1995; 17(6):501-7. PubMed ID: 8668583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatitis C].
    Viola LA; Fernández JL
    Acta Gastroenterol Latinoam; 1992; 22(2):133-4. PubMed ID: 1338677
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of viral hepatitis C: what are the perspectives?].
    Giostra E; Malè PJ
    Rev Med Suisse Romande; 1994 Sep; 114(9):759-64. PubMed ID: 7939106
    [No Abstract]   [Full Text] [Related]  

  • 10. [When should the treatment with interferon alpha be discontinued in chronic hepatitis C?].
    Castilla Cortázar A
    Med Clin (Barc); 1993 Dec; 101(20):774-6. PubMed ID: 8114538
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon therapy in renal allograft recipients with chronic hepatitis C.
    Harihara Y; Kurooka Y; Yanagisawa T; Kuzuhara K; Otsubo O; Kumada H
    Transplant Proc; 1994 Aug; 26(4):2075. PubMed ID: 8066675
    [No Abstract]   [Full Text] [Related]  

  • 13. [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
    Marcellin P; Pouteau M; Martinot M; Boyer N; Castelnau C; Benhamou JP; Erlinger S
    Gastroenterol Clin Biol; 1995 Dec; 19(12):991-1000. PubMed ID: 8729410
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-related hepatitis.
    Whelton MJ
    QJM; 1994 Oct; 87(10):589-91. PubMed ID: 7987653
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic viral hepatitis due to the hepatitis C virus (HCV): treatment experience with lymphoblast interferon-alpha].
    Foti G; De Cicco M; Masseo A; Mangano C; Tripodi A; Foti N
    Minerva Med; 1996; 87(1-2):53-5. PubMed ID: 8610026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with interferon-alpha in chronic hepatitis C. A gradual discontinuation of the drug till the end of the therapy can reduce disease recurrence].
    Bellobuono A; Bellati G; Mondazzi L; Tempini S; Fesce E; Idéo GM; Idéo G
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):107-11. PubMed ID: 7619955
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of daily administration period of natural alpha-interferon in patients with chronic hepatitis C.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S
    Am J Gastroenterol; 1996 Apr; 91(4):743-7. PubMed ID: 8677941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.